Clin2
NCT07184385Possibly a fitNot yet recruiting

Cord blood infusion for long COVID

Long COVIDPost-COVID-19 ConditionPost-COVID SyndromePost-COVID Condition

Part of Infections, Lungs & breathing clinical trials.

This trial tests a treatment made from donated umbilical cord blood, called REGENECYTE, to see if it helps people with long COVID feel better. It is for adults who still have symptoms after COVID-19 and have tested negative for the virus recently.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
60 people
Ages
18 years to 65 years
Study type
Interventional

Who can take part

  • You are 18 years old or older.
  • You have been diagnosed with long COVID (post-COVID condition).
  • You have had a negative COVID-19 test in the last 7 days.
  • You are willing and able to attend regular clinic visits and complete study tasks.
  • You do not have a pre-existing terminal illness, immune disease, or neurological disorder that started before COVID.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06492798Recruiting· Phase 1/Phase 2
Stem cells for Long COVID: a safety and effectiveness study

This study tests whether a single infusion of mesenchymal stem cells can help with Long COVID symptoms—without causing serious side effects. It’s for people who are still struggling with COVID-related health problems months after their initial infection.

Shanghai
NCT06992401Not yet recruiting
Nasal IVIG study for long COVID patients with immune problems

This study tests whether a nasal spray form of IVIG (an immune-boosting treatment) can help people with Long COVID who also have certain immune system issues. It aims to see if the treatment is safe and effective for this group of patients.

NCT07316127Recruiting· Phase 2
Blood filtering for autoimmune long COVID

This trial tests if filtering certain antibodies from the blood can help people with long COVID who experience post-exertional malaise (PEM) and reduced function. It aims to see if this treatment reduces symptoms and improves daily life.

Amsterdam
NCT06456502Recruiting
Non-invasive brain stimulation for long COVID symptoms

This trial tests whether a gentle, non-invasive brain stimulation device can help relieve long COVID symptoms. It involves wearing special gloves and socks that deliver mild electrical pulses to improve how you feel.

Alcorcón, Madrid
NCT07498504Not yet recruiting
Long-term impact of COVID-19 in adults

This study looks at how COVID-19 affects people in the long term. It aims to understand the lasting symptoms (often called long COVID) and how they impact your daily life. You may join if you have ongoing symptoms after COVID-19 that bother you or reduce your quality of life.

New York, New York
NCT06928272Recruiting· Phase 3
Long COVID drug study for adults 18 to 65

This study tests whether a commonly used drug (repurposed) can help improve Long COVID symptoms like fatigue, breathing problems, or brain fog. It is for adults 18 to 65 who had COVID-19 in the past 4 years and still have symptoms after 3 months.

San Diego, California

Hear when a new Long COVID trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.